Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets

· Camber Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, covering 2022-01-24 to 2022-01-24. Get the full timeline:

Most recent: FDA Approved: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Camber Pharmaceuticals, Inc.)

See pricing